Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Zimetbaum

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Annals of Internal Medicine|December 3, 2019
Should This Patient Be Screened for Atrial Fibrillation?: Grand Rounds Discussion From Beth Israel Deaconess Medical CenterRisa B Burns, Peter Zimetbaum, Steven A Lubitz, et al.
The American Journal of Cardiology|June 14, 2003
Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutterThomas H Hauser, Duane S Pinto, Mark E Josephson, et al.
Heartrhythm Case Reports|May 12, 2017
Persistent sinus node suppression caused by thrombotic occlusion of an arteriovenous fistula: A report of two casesHenry D Huang, Jonathan W Waks, Mark E Josephson, et al.
Pacing and Clinical Electrophysiology : PACE|October 10, 2013
The importance of atrial fibrillation burden and the origin of device-tailored anticoagulationPeter Zimetbaum, Ethan R Ellis, Jonathan W Waks, et al.
The American Journal of Cardiology|April 28, 2004
Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutterThomas H Hauser, Duane S Pinto, Mark E Josephson, et al.
Heart Rhythm|February 28, 2016
Magnitude of increase in QTc interval after initiation of dofetilide in patients with persistent atrial fibrillation is associated with increased rates of pharmacological cardioversion and long-term freedom from recurrent atrial fibrillationHenry D Huang, Jonathan W Waks, Daniel A Steinhaus, et al.
American Heart Journal|December 13, 2006
Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) studyMatthew R Reynolds, Tara Lavelle, Vidal Essebag, et al.
Journal of the American College of Cardiology|January 21, 2022
Lead-Related Venous Obstruction in Patients With Implanted Cardiac Devices: JACC Review Topic of the WeekPeter Zimetbaum, Brett J Carroll, Andrew H Locke, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2006
Assessing the direct costs of treating nonvalvular atrial fibrillation in the United StatesKarin S Coyne, Clark Paramore, Susan Grandy, et al.
Cardiology in Review|September 17, 2020
Arrhythmia in Cardiac SarcoidosisAndrew H Locke, Michael I Gurin, Marwa Sabe, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Annals of Internal Medicine|December 3, 2019
Should This Patient Be Screened for Atrial Fibrillation?: Grand Rounds Discussion From Beth Israel Deaconess Medical CenterRisa B Burns, Peter Zimetbaum, Steven A Lubitz, et al.
The American Journal of Cardiology|June 14, 2003
Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutterThomas H Hauser, Duane S Pinto, Mark E Josephson, et al.
Heartrhythm Case Reports|May 12, 2017
Persistent sinus node suppression caused by thrombotic occlusion of an arteriovenous fistula: A report of two casesHenry D Huang, Jonathan W Waks, Mark E Josephson, et al.
Pacing and Clinical Electrophysiology : PACE|October 10, 2013
The importance of atrial fibrillation burden and the origin of device-tailored anticoagulationPeter Zimetbaum, Ethan R Ellis, Jonathan W Waks, et al.
The American Journal of Cardiology|April 28, 2004
Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutterThomas H Hauser, Duane S Pinto, Mark E Josephson, et al.
Heart Rhythm|February 28, 2016
Magnitude of increase in QTc interval after initiation of dofetilide in patients with persistent atrial fibrillation is associated with increased rates of pharmacological cardioversion and long-term freedom from recurrent atrial fibrillationHenry D Huang, Jonathan W Waks, Daniel A Steinhaus, et al.
American Heart Journal|December 13, 2006
Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) studyMatthew R Reynolds, Tara Lavelle, Vidal Essebag, et al.
Journal of the American College of Cardiology|January 21, 2022
Lead-Related Venous Obstruction in Patients With Implanted Cardiac Devices: JACC Review Topic of the WeekPeter Zimetbaum, Brett J Carroll, Andrew H Locke, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2006
Assessing the direct costs of treating nonvalvular atrial fibrillation in the United StatesKarin S Coyne, Clark Paramore, Susan Grandy, et al.
Cardiology in Review|September 17, 2020
Arrhythmia in Cardiac SarcoidosisAndrew H Locke, Michael I Gurin, Marwa Sabe, et al.
Pageof 11